Preparation, Evaluation and Characterization of Antihypertensive Drug for Matrix Transdermal Patches

Authors

  • Mr. Saurabh Jawahar Sanghavi  Research Scholar, Mansarovar Global University, Sehor MP, India
  • Abhishek Suna  National Institute of Pharmaceutical Education and Research, Raebareli, India
  • Ms. Pratibha Pradip Deshmukh  PDEA’s Seth Govind Raghunath Sable College of Pharmacy, Saswad, Pune, India
  • Vikash Singh Bhadouria  Sharda University Greater Noida, Uttar Pradesh, India
  • Jyotsna Kharbanda  Sharda University Greater Noida, Uttar Pradesh, India
  • Divya Thirumal  Chitkara College of Pharmacy, Punjab, India \Dr. Bhanuben Nanavati College of Pharmacy , Mumbai, India
  • Ishan Shah  Samarth Institute of Pharmacy, Pune, India
  • Kurhade Rupesh Ramdas   

Keywords:

TDDS, Nicorandil , transdermal patch , PVA membrane, Skin permeation

Abstract

Nicorandil belongs to the elegance of potassium channel activators, which exert their transfer through arterio-dilating and vasodilating properties and represents a unique form of compound for use withinside the treatment of angina pectoris. It has a short ½ of existence and the usual oral dosage routine is 5-40mg taken to 4 times a day. V G Jamakandi et al., employed solvent casting technique to formulate HPMC patches containing specific grades of HPMC polymer (6 cps, 15 cps and K4M) as matrix base, polyethylene glycol as plasticizer and DMSO as penetration enhancer. Prepared matrix type patches were evaluated for their physicochemical characterization followed through in-vitro and ex-vivo studies on porcine ear pores and skin. The quit end result shows transdermal patch with 6 cps 2% w/v HPMC,30% w/v PEG 400 and 6%w/v DMSO as a penetration enhancer showed a maximum release (44.7%) and it offers least resistance for the drug movement due to its immoderate hydrophilic nature and immoderate water permeability value to water. Transdermal Drug Delivery System is the system in which the delivery of the active ingredients of the drug occurs by the means of skin. Skin is an effective medium from which absorption of the drug takes place and enters the circulatory system. Various types of transdermal patches are used to incorporate the active ingredients into the circulatory system via skin. The patches have been proved effective because of its large advantages over other controlled drug delivery systems .

References

  1. Sankar V et al.: Design and evaluation of nifedipine transdermal Patches. Indian Journal of Pharmaceutical Sciences 2003; 65(5):510-515.
  2. Pandey S, Praveen SH and Udupa N: Formulation and Evaluation of nimesulide transdermal drug delivery systems. Indian Journal of Pharmaceutical Sciences 2000; 62(5):376-379.
  3. Chien Y W. In: Transdermal controlled systemic medication. Marcel Dekker, New York, First edition 1976.
  4. Mandal Sonjoy, Thimmasetty J, Ratan GN and Kilarimath BH: Formulation and evaluation of carvedilol transdermal patches. International Research Journal of Pharmacy 2011; 2(1):237-248.
  5. Kshirsagar NA: Drug delivery systems. Indian Journal of Pharmacology 2000; 32:S54- S61.
  6. Mohd A, Asgar A, Yasmin S, Kiran D, Abul KN and Kollapa KP: In vivo characterization of monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: A technical note. AAPS Pharm. Sci. Tech. 2006; 7(1):E1-E5.
  7. Liang Fang et al.: Design and in vivo evaluation of an indapamide transdermal patch. International Journal of Pharmaceutics 2009; 370:129–135.
  8. Hoyert DL, Kung HC and Smith BL: Deaths: preliminary data for 2003. National Vital Statistics Reports 2005; 53:1–48.
  9. Kim J and Kitakaze M: Prevention and treatment of the Hypersensitive organopathy—the necessity of cardiovascular Protection. Nippon Rinsho 2004; 62:120–127.
  10. Jayaraj Kumar K, Suneetha KC, Uma Devi SK, Sai Prasanthi N, Pravalika Ch, Lakshmi Prasanna. D, Kalayan Babu P and Venkateswarlu A: Brief view on delivery of antihypertensive drugs through transdermal patches. Journal of Innovative trends in Pharmaceutical Sciences 2010; 1 (7):305-319.
  11. Jamakandi VG, Mulla JS, Vinay BL and Shivakumar HN: Formulation, characterization, and evaluation of matrix-type Transdermal patches of a model antihypertensive drug. Asian Journal of Pharmaceutics 2009; 3:59-65.
  12. Shaila L, Pandey S, Udupa N. Design and evaluation of matrix type and membrane controlled transdermal delivery systems of nicotine suitable for use in smoking cessation. Indian J Pharm Sci 2006;68:179-84.
  13. Barry BW. Novel mechanism and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001;14:101-14.
  14. Wade Hull MS. Heat-enhanced transdermal drug delivery: A survey Paper. J Appl Res 2002;2:1-9.
  15. Krishnaiah YS, Chandrasekhar DV, Rama B, Jayaram B, satyanarayana V, Al-Saidan SM. In vivo evaluation of limonene-based transdermal therapeutic system of nicorandil in healthy human volunteers. Skin Pharmacol Physiol 2004;18:263-72.
  16. Chein YW. Transdermal drug delivery systems and delivery systems. 2nd. Marcel Dekker, Inc; 1992. P. 301.
  17. Libermann and Lachman. Pharmaceutical dosage forms. 2nd ed. Lea and Febiger; 1990. P. 265.
  18. Shukla AJ, Lee JC. Handbook of pharmaceutical excipients. 2nd ed. In: Wade A, Wellers PJ, editors. American Pharmaceutical Association and Royal Pharmaceutical society of Great Britain 1994. P. 362-6.
  19. Shah HS, Tojo K, Chien YW. Transdermal controlled delivery of Verapamil: Characterization of in vitro skin permeation. Int J Pharm 1992;86:167-73.
  20. Squillante E, Needham T, Zia H. Solubility and in vitro transdermal Permeation of nifedipine. Int J Pharm 1997;159:171-80.
  21. Ghosh TK, Adir J, Xiang S, Onyilofur S. Transdermal delivery of Metoprolol II: In vitro skin permeation and bioavailability in hairless rats. J Pharm Sci 1995;84:158-60

Downloads

Published

2022-06-30

Issue

Section

Research Articles

How to Cite

[1]
Mr. Saurabh Jawahar Sanghavi, Abhishek Suna, Ms. Pratibha Pradip Deshmukh, Vikash Singh Bhadouria, Jyotsna Kharbanda, Divya Thirumal, Ishan Shah, Kurhade Rupesh Ramdas "Preparation, Evaluation and Characterization of Antihypertensive Drug for Matrix Transdermal Patches " International Journal of Scientific Research in Science and Technology(IJSRST), Online ISSN : 2395-602X, Print ISSN : 2395-6011,Volume 9, Issue 3, pp.140-147, May-June-2022.